🟢 HCW Biologics is trading 11% up in pre-market — no clear catalyst identified

HCW Biologics is trading 11.04% up at $3.63 in pre-market, with no clearly identified company-specific announcement on August 11, 2026.

• Recent coverage cites a $1.6 million private placement announced July 29, but the news is stale and does not directly explain the move.
• Earnings estimates range from August 11 to August 17.
• The broader market is essentially flat; reliable trading activity details were unavailable.